
Ingredion delivers record 2025 results as "texture" growth outpaces inflation
Ingredion (NYSE:INGR) reported record full-year 2025 results on Tuesday, underscoring the resilience of its high-margin specialty ingredients despite operational headwinds in North America.
The Westchester, Illinois-based provider of starch and sweetener solutions posted full-year reported EPS of $11.18 and adjusted EPS of $11.13, surpassing 2024’s performance of $9.71 and $10.65, respectively.
The company’s growth was primarily powered by its Texture & Healthful Solutions segment, which saw robust demand for "clean label" ingredients as food manufacturers reformulated recipes to appeal to health-conscious consumers.
This specialty segment helped offset slower-than-expected recovery at the company's Argo plant in Illinois, which had faced production disruptions earlier in the year.
Full-year operating income reached $1.016 billion, while the company generated a formidable $944 million in cash from operations.
Looking ahead, Ingredion issued 2026 guidance that anticipates continued top-line momentum, with net sales expected to rise by low- to mid-single digits.
The company projects adjusted EPS in the range of $11 to $11.80, supported by lower raw material input costs and improved operational efficiencies in the U.S. and Canada.
While cash from operations is forecast to dip slightly to between $820 million and $940 million due to working capital timing, management expects segment operating income to remain on an upward trajectory.
More from United States
C3is reports $1.2 million Q3 net loss as revenue rises
Cosmos Health revenue hits $53.6 million, up 17.6%
Summit launches Phase III lung cancer trial for ivonescimab
DataMeds AI issues 630,000 shares in cancer partnership
CoinShares net income improves 27% to $39.6 million
newcleo revenue skyrockets 26% to €10 million in Q3